Mannitol Administration Guidelines

Introduction to Mannitol Administration

The American Academy of Pediatrics recommends administering mannitol as an intravenous bolus of 0.25-1 g/kg over 20-30 minutes for elevated intracranial pressure, with smaller doses being as effective as larger doses for acute ICP reduction while minimizing complications 1

The standard initial dose of mannitol is 0.25-1 g/kg IV over 20-30 minutes, as recommended by the American Academy of Pediatrics 2, 1
For acute intracranial hypertensive crisis, larger doses of 0.5-1 g/kg over 15 minutes may be appropriate, according to the American Academy of Pediatrics 2, 1
Smaller doses of 0.25 g/kg are equally effective as larger doses of 0.5-1 g/kg for acute ICP reduction, with ICP decreasing from approximately 41 mm Hg to 16 mm Hg regardless of dose, as stated by the American Academy of Pediatrics 1
The maximum daily dose of mannitol is 2 g/kg, as recommended by the American Academy of Pediatrics 1

The American Academy of Pediatrics recommends using a filter in the administration set when infusing 25% mannitol 2
Peak effect of mannitol occurs at 10-15 minutes after administration, with effects lasting 2-4 hours, according to the American Academy of Pediatrics 1

The American Association for the Study of Liver Diseases recommends monitoring serum osmolality frequently and discontinuing mannitol when it exceeds 320 mOsm/L to prevent renal failure 3, 1
Serum osmolality increases of ≥10 mOsm are associated with effective ICP reduction, as stated by the American Academy of Pediatrics 1

Mannitol should be used in conjunction with other ICP control measures, such as hyperventilation, sedation and analgesia, head-of-bed elevation, and cerebrospinal fluid drainage, as recommended by the American Academy of Pediatrics and the American Association for the Study of Liver Diseases 2, 3, 1

The American Society of Nephrology states that patients with pre-existing renal disease are at increased risk of renal complications with mannitol administration 4
The American Academy of Pediatrics recommends avoiding concomitant administration of nephrotoxic drugs or other diuretics with mannitol 1
Hypertonic saline is preferable over mannitol when hypovolemia or hypotension is present, as stated by the American Academy of Pediatrics 1

The American Association for the Study of Liver Diseases recommends not using mannitol prophylactically, but only for documented elevated ICP or clinical signs of herniation 3, 5, 1
The American Academy of Pediatrics states that continuous infusion of mannitol should not be used instead of bolus dosing, and that serum osmolality should not exceed 320 mOsm/L 3, 1